Our mission is to enhance the quality of management and precision of treatment for cancer patients

Every tumor has its own distinct set of genetic, transcriptomic and phenotypic signatures. This uniqueness is what causes disease progression and therapy response to differ from patient to patient. 

Therefore, it is paramount that we examine and treat individual tumors as such and design a personalized clinical management and treatment plan centered around their unique characteristics.

To do so, we are leveraging on our novel device: fluidic Tumor Avatar System, f(TAS) to grow patient tumors under human-like conditions. This allows us to simulate and predict how a patient’s disease may progress and to match patients to the right drugs.

This will allow us to formulate a comprehensive personalized clinical management plan which covers: 

• 1. The risk of tumor recurrence and how often a patient should have clinical follow-up

  2. If the patient will respond to current treatment and alternative precision therapies

Technology

Each different tumor exhibits a unique growth characteristic in our f(TAS) system. The f(TAS) has a wide dynamic range able to capture specific phenotypic characteristics ranging from benign to metastatic tumors. 

We are working to bring you more content.

Interested to know more?

Contact us @ info@prescidx.com